Arca
Skip to content
Tools
Tools

ODC1: Ornithine decarboxylase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who Is On It, and How Far Along

Every drug ChEMBL records acting on ODC1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved1

  • Eflornithine

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionMechanismOpen trialsWarnings
        EflornithineApprovedSanofiSmall moleculeInhibitorOrnithine decarboxylase inhibitor17—

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasEflornithinePhase 1 / Phase 2RecruitingMayo Clinic2026-03-12
        Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaEflornithinePhase 2RecruitingMilton S. Hershey Medical Center2026-01-07
        Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsEflornithinePhase 1 / Phase 2RecruitingAminex Therapeutics, Inc.2025-12-17
        Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma(CSHEIN)Eflornithine—Active, not recruitingShanghai Children's Hospital2025-12-12
        Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in FemaleEflornithinePhase 4RecruitingKhyber Teaching Hospital2025-05-16
        DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or OsteosarcomaEflornithinePhase 1 / Phase 2RecruitingMontefiore Medical Center2025-03-25
        Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasEflornithinePhase 1 / Phase 2RecruitingMilton S. Hershey Medical Center2024-06-18
        Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerEflornithinePhase 2RecruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2023-09-28

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Neurodevelopmental disorder with alopecia and brain abnormalities
        0.74
        Human African trypanosomiasis
        0.48
        Hirsutism
        0.46
        Neoplasm
        0.40
        Neurodevelopmental disorder
        0.37
        Autoimmune disorder of central nervous system
        0.35
        Classic familial adenomatous polyposis
        0.33
        Musculoskeletal system disorder
        0.32
        Neurodegenerative disease
        0.31

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1869, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P11926, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.